146 related articles for article (PubMed ID: 12038194)
1. [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].
Fuchs WJ; Riebenfeld D
Praxis (Bern 1994); 2002 Apr; 91(17):735-42. PubMed ID: 12038194
[TBL] [Abstract][Full Text] [Related]
2. An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.
Ansoms C; Deckers F; Lehert P; Pelc I; Potgieter A
Eur Addict Res; 2000 Sep; 6(3):132-40. PubMed ID: 11060477
[TBL] [Abstract][Full Text] [Related]
3. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
4. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
5. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
[TBL] [Abstract][Full Text] [Related]
6. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
Besson J; Aeby F; Kasas A; Lehert P; Potgieter A
Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate in alcohol dependence: how does it work?
Littleton J
Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
[TBL] [Abstract][Full Text] [Related]
8. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
[No Abstract] [Full Text] [Related]
9. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.
de Sousa A; de Sousa A
Alcohol Alcohol; 2005; 40(6):545-8. PubMed ID: 16043433
[TBL] [Abstract][Full Text] [Related]
10. [Preventing recurrence after alcohol withdrawal treatment with drugs. Reducing the drive to drink].
MMW Fortschr Med; 2003 May; 145(19):56. PubMed ID: 12813988
[No Abstract] [Full Text] [Related]
11. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
[TBL] [Abstract][Full Text] [Related]
12. [Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].
Smolka MN; Kiefer F; Mann K
MMW Fortschr Med; 2003 Sep; 145(35-36):45. PubMed ID: 14584210
[No Abstract] [Full Text] [Related]
13. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
[TBL] [Abstract][Full Text] [Related]
14. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
[TBL] [Abstract][Full Text] [Related]
15. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
[TBL] [Abstract][Full Text] [Related]
16. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological relapse prevention in alcohol and tobacco dependence].
Diehl A; Mann K
Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
[TBL] [Abstract][Full Text] [Related]
19. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
Lejoyeux M; Lehert P
Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological treatment of alcohol dependence: needs and possibilities.
Mann K
Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
